Stockreport

Innovus Pharma Expands its OTC Drug Pipeline with the Addition of OmepraCare™ (a Competitor of Prilosec® OTC)

InnovAge Holding Corp.  (INNV) 
NASDAQ:AMEX Investor Relations: innovuspharma.com
PDF This New Drug OmepraCare™ is Indicated for the Treatment of Frequent Heartburn and is Expected to add Significant Revenue to the Company SAN D [Read more]